Source:http://linkedlifedata.com/resource/pubmed/id/19047902
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-19
|
pubmed:abstractText |
To evaluate whether p16 staining could help to recognize underestimated cervical intraepithelial neoplasia (CIN) in women positive for high-risk human papillomavirus (HR-HPV) with negative biopsy. Out of 1,259 women undergoing a histologic study and a simultaneous HR-HPV detection using the Hybrid Capture 2 test, we selected all patients testing positive for HR-HPV and having a negative biopsy (n=139), as well as all women testing negative for HR-HPV with a biopsy of either CIN 1 (26 cases) or CIN 2 to 3 (11 cases). Of the remaining 1,083 women, we randomly selected for the purpose of controls, 50 cases negative for HR-HPV with negative biopsy and 100 cases positive for HR-HPV and with biopsy of CIN (50 CIN 1, 50 CIN 2-3). In all cases, immunohistochemical staining for p16 and a second evaluation of the initial biopsy was carried out. Thirty-four out of 139 biopsies (24.5%) testing positive for HR-HPV but having a negative biopsy were positive for p16. Thirty of these cases (21.6%) were classified as harboring a CIN (11 CIN 1, 19 CIN 2/3) after reevaluation. Both the number of cases reclassified as CIN of any grade, or as CIN 2/3, were significantly higher for cases with HR-HPV load above 100 relative light unit (P<0.005). Particular attention should be paid to biopsies from patients having positive Hybrid Capture 2. The risk of harboring undetected CIN of any type or CIN 2/3 is significantly higher for patients with high HR-HPV load. Immunostaining with p16 should be considered as a highly desirable addition to the histologic evaluation of cervical biopsy specimens in HR-HPV-positive women.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1538-7151
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
90-7
|
pubmed:meshHeading |
pubmed-meshheading:19047902-Adolescent,
pubmed-meshheading:19047902-Adult,
pubmed-meshheading:19047902-Aged,
pubmed-meshheading:19047902-Aged, 80 and over,
pubmed-meshheading:19047902-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:19047902-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:19047902-Female,
pubmed-meshheading:19047902-Humans,
pubmed-meshheading:19047902-Immunohistochemistry,
pubmed-meshheading:19047902-Middle Aged,
pubmed-meshheading:19047902-Papillomaviridae,
pubmed-meshheading:19047902-Papillomavirus Infections,
pubmed-meshheading:19047902-Tumor Markers, Biological,
pubmed-meshheading:19047902-Uterine Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women.
|
pubmed:affiliation |
Department of Pathology, School of Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain. jordi@clinic.ub.es
|
pubmed:publicationType |
Journal Article
|